JP2003159325A - Hemodialyzer and manufacturing method thereof - Google Patents

Hemodialyzer and manufacturing method thereof

Info

Publication number
JP2003159325A
JP2003159325A JP2001363791A JP2001363791A JP2003159325A JP 2003159325 A JP2003159325 A JP 2003159325A JP 2001363791 A JP2001363791 A JP 2001363791A JP 2001363791 A JP2001363791 A JP 2001363791A JP 2003159325 A JP2003159325 A JP 2003159325A
Authority
JP
Japan
Prior art keywords
hollow fiber
hemodialyzer
blood
bundle
fiber bundle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001363791A
Other languages
Japanese (ja)
Other versions
JP4069998B2 (en
Inventor
Toshiji Uwazumi
敏士 上住
Takeshi Iwasaki
武士 岩崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Medical Co Ltd
Original Assignee
Asahi Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Medical Co Ltd filed Critical Asahi Medical Co Ltd
Priority to JP2001363791A priority Critical patent/JP4069998B2/en
Publication of JP2003159325A publication Critical patent/JP2003159325A/en
Application granted granted Critical
Publication of JP4069998B2 publication Critical patent/JP4069998B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a means for reducing blood residue on a contact surface of an embedded portion of a hollow string bundle of the hemodialyzer and a variation in the capability of the dialyzer to remove substances after treatment with the hemodialyzer whose hollow string bundle is inserted in a tube shaped plastic vessel and both ends of the bundle are embedded with a potting material. <P>SOLUTION: A share percentage of the hollow string bundle in a contact portion of blood in the embedded portion of the hollow string bundle in the hemodialyzer of a tube shaped plastic type is set to not less than 87 percent in relation to an inner diameter of the vessel. Further, an offset of the roundness of the hollow string bundle on the surface to contact blood in the embedded portion of the hollow string bundle is set to not more than 3 percent. This kind of hemodialyzer whose hollow string bundle wound like a film in advance is placed between a plurality of rollers with different peripheral velocities and allowed to rotate for a fixed length of time before it is inserted in the tube shaped plastic vessel and finally manufactured when fixed with the potting material. <P>COPYRIGHT: (C)2003,JPO

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は血液透析器およびそ
の製造方法に関する。
TECHNICAL FIELD The present invention relates to a hemodialyzer and a method for manufacturing the same.

【0002】[0002]

【従来の技術】従来、血液透析療法あるいは濾過療法な
どに使用される血液透析器は、血液中に蓄積した老廃物
あるいは有害物を、拡散、濾過などの原理に基づき血中
から除去することを目的とし、20世紀半ばにドラム型血
液透析器として実用化されてから、現在においても腎機
能が一部または完全に喪失した患者の治療用途に用いら
れ有効に利用されている。老廃物あるいは有害物の除去
は主として膜を介し行われるのが一般的であり、膜の材
質としては、再生セルロースからなる膜や、たとえばポ
リアクリロニトリルやポリスルホン、ポリエチレンなど
の合成高分子からなる膜が公知であり、形状は、平膜あ
るいは中空糸膜があるが、近年は血液との接触面積が大
きくでき処理能力の高い中空糸状の膜が多く用いられて
いる。
2. Description of the Related Art Conventionally, a hemodialyzer used for hemodialysis therapy or filtration therapy is designed to remove waste or harmful substances accumulated in blood from the blood based on the principle of diffusion or filtration. Since it was first put into practical use as a drum type hemodialyzer in the middle of the 20th century, it is still being used effectively for the treatment of patients with partial or complete loss of renal function. Removal of wastes or harmful substances is generally carried out mainly through a membrane, and as a material of the membrane, a membrane made of regenerated cellulose or a membrane made of a synthetic polymer such as polyacrylonitrile, polysulfone or polyethylene is used. Although it is publicly known and has a flat membrane or a hollow fiber membrane, in recent years, a hollow fiber membrane having a large contact area with blood and high processing ability has been widely used.

【0003】さらに血液透析器の形状は、中空糸膜であ
れば数百から数万本を束ねて円筒形プラスチック製容器
に装填した後、主にポリウレタン樹脂を充填して中空糸
を容器に固定し半製品を作成して、さらに血液を導入す
る部品を取り付け、滅菌処理を行って血液透析器とされ
る。また、血液処理にあたっては、中空糸を用いた血液
透析器の場合には、中空糸内側に血液を流し、さらにそ
の外側には無機電解質等を含んだ透析液を流して、血液
の除去対象物質を透析液側に拡散あるいは濾過して除去
している。
Further, the shape of the hemodialyzer is that if hollow fiber membranes are bundled, hundreds to tens of thousands are bundled and loaded into a cylindrical plastic container, and then a polyurethane resin is mainly filled to fix the hollow fibers to the container. Then, a semi-finished product is created, and a part for introducing blood is attached, and sterilization is performed to obtain a hemodialyzer. Further, in blood treatment, in the case of a hemodialyzer using a hollow fiber, blood is allowed to flow inside the hollow fiber, and a dialysate containing an inorganic electrolyte or the like is allowed to flow outside the hollow fiber to remove the target substance of blood. Is removed by diffusion or filtration on the dialysate side.

【0004】透析治療においては、血液を透析器に導入
して所定時間血液を循環した後に、透析器内に残留した
血液を生理食塩水によって押し出し、体内に戻す操作を
行っている。その際、中空糸内だけではなく、血液を導
入する部分に血液が残留する場合があり、そのため中空
糸包埋部の血液との接触面形状を工夫する方法(特開平
4-309360号)が考案されているが、複雑な形状となるた
め、生産性が下がりコストアップする要因となってい
た。
In dialysis treatment, blood is introduced into a dialyzer and circulated for a predetermined time, and then blood remaining in the dialyzer is pushed out by physiological saline and returned to the body. At that time, the blood may remain not only in the hollow fiber but also in the part where the blood is introduced. Therefore, a method of devising the shape of the contact surface of the hollow fiber-embedded part with blood (Japanese Patent Laid-Open No. Hei 10 (1999) -242242).
No. 4-309360) was devised, but its complicated shape had a factor of reducing productivity and cost.

【0005】また、血液透析器の物質除去性能を決定す
る主な要因は、血液あるいは透析液と直接接する中空糸
の性能、即ち物質移動係数であり、従来から中空糸の素
材、物質を透過する孔径の大きさや分布、透過抵抗を決
める膜の厚みなどが検討され実用化されてきた。一方、
これら中空糸の性能を最大限に発現させるためには、透
析器容器の形状が重要な役割を果たしており、中空糸内
外の圧力損失、すなわち容器長と容器内径の関係や、透
析器容器の長手方向中央付近に中空糸がどれぐらい密に
詰まっているかを示す充填率などが検討され実用化され
てきた。
Further, the main factor that determines the substance removal performance of a hemodialyzer is the performance of the hollow fiber that is in direct contact with blood or dialysate, that is, the mass transfer coefficient, which has conventionally permeated the material and substance of the hollow fiber. The size and distribution of the pore size and the thickness of the membrane that determines the permeation resistance have been studied and put to practical use. on the other hand,
In order to maximize the performance of these hollow fibers, the shape of the dialyzer container plays an important role.The pressure loss inside and outside the hollow fiber, that is, the relationship between the container length and the container inner diameter, and the length of the dialyzer container The filling rate, which indicates how densely the hollow fibers are packed near the center in the direction, has been studied and put to practical use.

【0006】さらに、透析液流れを均一にして除去効率
を上げるとともに、除去性能のバラツキを少なくする工
夫として、中空糸間にスペーサーフィラメントを入れる
方法(特許第3080430 号、特公昭59-18084号、特開平8-
246283号)や、中空糸をクリンプと呼ばれる小さな波型
にする方法(特公昭 57-194007号)などが考案されてい
るが、これらの方法は、例えばスペーサーフィラメント
入り中空糸束については、スペーサーフィラメントを中
空糸間に挿入する、或いはスペーサーフィラメントで中
空糸を編むような複雑な技術を要し、またクリンプ糸に
ついては、波型部で中空糸が折れたり、閉塞したりする
場合があり、生産性に劣る面があった。
[0006] Further, as a device to make the flow of dialysate uniform to improve the removal efficiency and reduce the variation in the removal performance, a method of inserting a spacer filament between the hollow fibers (Japanese Patent No. 3080430, Japanese Patent Publication No. 59-18084, Japanese Patent Laid-Open No. 8-
No. 246283) or a method of making a hollow fiber into a small corrugated shape called crimp (Japanese Patent Publication No. Sho 57-194007). These methods are, for example, for a hollow fiber bundle containing a spacer filament, a spacer filament. Requires a complicated technique such as inserting between the hollow fibers or knitting the hollow fibers with a spacer filament.For crimped yarns, the hollow fibers may be broken or clogged at the corrugated part. There was a side inferior in sex.

【0007】[0007]

【発明が解決しようとする課題】本発明は、血液透析治
療後、血液透析器の中空糸包埋部の血液接触面における
血液残留を少なくすること、透析器の物質除去性能のバ
ラツキを減少させることを目的とするものである。さら
に、前記課題を解決する非常に簡便な製造方法を提供す
ることを目的とする。
DISCLOSURE OF THE INVENTION The present invention reduces the residual blood on the blood contact surface of the hollow fiber embedding part of the hemodialyzer after the hemodialysis treatment and reduces the variation in the substance removal performance of the dialyzer. That is the purpose. Further, it is an object of the present invention to provide a very simple manufacturing method which solves the above problems.

【0008】[0008]

【課題を解決するための手段】発明者らは、前記課題を
解決するために、中空糸束形状、および中空糸包埋部に
おける中空糸束の存在状態を鋭意検討した結果、驚くべ
き事に中空糸のポッティング材による包埋部における中
空糸の存在状態を特定の状態にすることにより、血液透
析治療後、血液透析器の中空糸包埋部にある血液接触面
に血液の残留が少なくなること、さらに透析器の物質除
去性能のバラツキを減少させることが可能なことを見い
だした。また、これら課題を達成する製造方法を検討し
た結果、筒状プラスチック容器に挿入する前に中空糸束
の形状を整える方法を見出し、本発明をなすに至った。
Means for Solving the Problems In order to solve the above-mentioned problems, the inventors have made earnest studies as to the shape of the hollow fiber bundles and the state of existence of the hollow fiber bundles in the hollow fiber embedded portion. The presence of hollow fibers in the embedding part of the hollow fiber potting material makes the existence state of the hollow fiber in a specific state, so that blood remains less on the blood contact surface in the hollow fiber embedding part of the hemodialyzer after the hemodialysis treatment. It was further found that it is possible to further reduce the variation in the substance removal performance of the dialyzer. In addition, as a result of studying a manufacturing method for achieving these objects, a method for adjusting the shape of the hollow fiber bundle before inserting into a cylindrical plastic container was found, and the present invention was completed.

【0009】すなわち、本発明はかかる課題を達成する
ため、次のような構成を有する。 (1) 中空糸束が筒状プラスチック容器内に挿入され、束
の両端部がポッティング材で包埋された血液透析器にお
いて、中空糸包埋部の血液接触面における容器内径に対
する中空糸束の占有率が87%以上である血液透析器。 (2) 中空糸包埋部の血液接触面における中空糸束の真円
度偏りが3%以下である(1)記載の血液透析器。 (3) 中空糸の形状が繊維軸方向に沿って直線状である
(1) または (2)に記載の血液透析器。 (4) 中空糸の素材がポリスルホンを基材とする(1) 乃至
(3)のいずれかに記載の血液透析器。 (5) 中空糸束を筒状プラスチック容器内に挿入し、束の
両端部をポッティング材で包埋する血液透析器の製造方
法において、予めフィルム巻きされた中空糸束を周速度
の異なる複数のローラー間に置き、一定時間回転させた
後、筒状プラスチック容器に挿入しポッティング材で固
定する (1)乃至(4) のいずれかに 記載の血液透析器の
製造方法。
That is, the present invention has the following structure in order to achieve the above object. (1) In a hemodialyzer in which a hollow fiber bundle is inserted into a tubular plastic container and both ends of the bundle are embedded with potting material, a hollow fiber bundle with respect to the inner diameter of the container at the blood contact surface of the hollow fiber embedding part A hemodialyzer with an occupation rate of 87% or more. (2) The hemodialyzer according to (1), wherein the roundness deviation of the hollow fiber bundle on the blood contact surface of the hollow fiber embedded portion is 3% or less. (3) The shape of the hollow fiber is linear along the fiber axis
The hemodialyzer according to (1) or (2). (4) Hollow fiber material is based on polysulfone (1) to
The hemodialyzer according to any one of (3). (5) In the method for producing a hemodialyzer in which a hollow fiber bundle is inserted into a tubular plastic container and both ends of the bundle are embedded with potting material, a plurality of film-wound hollow fiber bundles having different peripheral speeds are used. The method for producing a hemodialyzer according to any one of (1) to (4), which is placed between rollers, rotated for a certain period of time, and then inserted into a cylindrical plastic container and fixed with a potting material.

【0010】[0010]

【発明の実施の形態】中空糸包埋部の血液接触面におけ
る容器内径に対する中空糸束の占有率は、血液透析器の
血液接触面における容器内径に対する中空糸束径の割合
を示し、以下により算出する。容器内径は血液透析器の
血液接触面における容器内径を少なくとも5箇所以上、
ノギス等を用いて測定し、その最大値および最小値の算
術平均値を容器内径とする。一方、中空糸束径は、中空
糸包埋部の血液接触面を正視し、極端に亀裂を生じたよ
うに束が割れている部分を除き、中空糸束の径を最低5
箇所以上測定して、最大径および最小径を求めた上で、
その算術平均値を中空糸束径として、下式(1) により占
有率を算出する。
BEST MODE FOR CARRYING OUT THE INVENTION The occupation ratio of the hollow fiber bundle to the inner diameter of the container on the blood contact surface of the hollow fiber embedding part indicates the ratio of the diameter of the hollow fiber bundle to the inner diameter of the container on the blood contact surface of the hemodialyzer. calculate. The inner diameter of the container should be at least 5 places on the blood contact surface of the hemodialyzer.
Measure with a caliper or the like, and use the arithmetic mean value of the maximum and minimum values as the container inner diameter. On the other hand, the diameter of the hollow fiber bundle should be at least 5 when the blood contact surface of the hollow fiber embedding part is directly viewed and the portion where the bundle is cracked as if an extreme crack had occurred.
After measuring at more than one point and obtaining the maximum and minimum diameters,
Using the arithmetic mean value as the hollow fiber bundle diameter, the occupancy rate is calculated by the following formula (1).

【0011】[0011]

【数1】 占有率 (%) = 100×中空糸束径÷容器内径 (1)[Equation 1] Occupancy rate (%) = 100 x hollow fiber bundle diameter ÷ container inner diameter (1)

【0012】すなわち、本試験における中空糸束の占有
率は、透析器容器の長手方向中央付近の内径を算出の基
準とし、容器内に中空糸がどれぐらい詰まっているかを
示す中空糸の容器内充填率とは異なり、ポッティング材
によって固定された血液接触面において、中空糸が如何
に広がっているかを示すパラメータである。発明者らは
この占有率に着目し、透析器の作成条件について詳細に
検討を加え占有率の大小と血液循環後に透析器内に残留
する血液の多少の関係を鋭意検討したところ、驚くべき
ことに、血液接触面における透析器容器に対する中空糸
束の占有率を87%以上、好ましくは90%以上とすること
により、血液導入部に残る血液が少なくなることを見出
した。この占有率の上限は、その定義から自ずと 100%
であるが、中空糸が容器内部に接触するまで占有率を上
げると、ウレタン樹脂等のポッティング材が浸透しにく
くなってピンホールを生じやすく、生産性を落とす為、
95%以下にすることが望ましい。占有率を87%以上とす
ることによって、かかる効果が得られる理由は、血液接
触面における透析器容器に対する中空糸束の占有率を大
きくすると、中空糸の存在しない血液接触面が小さくな
って血液循環中の滞留部分が小さくなり、血液凝固が起
こりにくく、また、血液を体内に返す操作を行う際に、
生理食塩水による返血操作が容易になって血液が残らな
いためと推測される。
That is, the occupancy rate of the hollow fiber bundle in this test is based on the inner diameter of the dialyzer container near the center in the longitudinal direction as a reference for calculation, and shows how much hollow fiber is packed in the container. Different from the filling rate, it is a parameter indicating how the hollow fibers spread on the blood contact surface fixed by the potting material. Focusing on this occupancy rate, the inventors conducted a detailed examination of the conditions under which the dialyzer was made, and made a thorough study of the relationship between the size of the occupancy rate and the amount of blood remaining in the dialyzer after blood circulation. It was also found that by setting the occupancy rate of the hollow fiber bundle to the dialyzer container on the blood contact surface to be 87% or more, preferably 90% or more, less blood remains in the blood introducing part. The upper limit of this occupancy rate is, by definition, 100%.
However, if the occupancy rate is increased until the hollow fibers come into contact with the inside of the container, the potting material such as urethane resin is difficult to penetrate and pinholes are easily generated, which reduces productivity,
It is desirable to be 95% or less. The reason why this effect is obtained by setting the occupancy rate to 87% or more is that when the occupancy rate of the hollow fiber bundle to the dialyzer container in the blood contact surface is increased, the blood contact surface in which the hollow fiber does not exist becomes smaller. The stagnation part in the circulation becomes small, blood coagulation does not occur easily, and when performing the operation of returning blood to the body,
It is presumed that the operation of returning blood with physiological saline becomes easy and no blood remains.

【0013】一方、本発明でいう中空糸包埋部の血液接
触面における中空糸束の真円度偏りとは、中空糸包埋部
の血液接触面を正視した時、中空糸束が真円を保ちポッ
ティングされているか、あるいはウレタン等のポッティ
ング材を注入する際に押し流されて変形している等の影
響を受けて偏っているかを数値化する尺度であり、以下
により算出する。すなわち、中空糸包埋部の血液接触面
を正視し、極端に亀裂を生じたように束が割れている部
分を除き、中空糸束の径を最低5箇所以上測定して、最
大径および最小径を求め、下式(2) により真円度を算出
する。
On the other hand, the uneven circularity of the hollow fiber bundle on the blood contact surface of the hollow fiber-embedded portion in the present invention means that the hollow fiber bundle has a perfect circularity when the blood contact surface of the hollow fiber-embedded portion is directly viewed. It is a scale for quantifying whether or not it is potted while keeping, or is biased by being affected by being deformed by being swept away when pouring a potting material such as urethane, and calculated by the following. That is, by directly looking at the blood contact surface of the hollow fiber embedding part, the diameter of the hollow fiber bundle is measured at a minimum of 5 points or more, excluding the portion where the bundle is broken as if it had extremely cracked, and the maximum diameter and the maximum diameter are measured. Obtain the small diameter and calculate the roundness using the following formula (2).

【0014】[0014]

【数2】 真円度偏り(%)= 100×(最大径−最小径)÷最小径 (2) [Equation 2]       Roundness deviation (%) = 100 x (maximum diameter-minimum diameter) ÷ minimum diameter (2)

【0015】本試験における真円度偏りは、血液接触面
における中空糸束径の偏りを示すパラメータであるが、
この偏りが小さいことは、束最大径と最小径の差が小さ
く、血液接触面に中空糸が真円状に均一に存在している
ことを示している。そこで、発明者らは真円度偏りに着
目し、透析器の作製条件について詳細に検討を加え真円
度偏りと透析器の物質除去性能の関係を鋭意検討したと
ころ、同じ本数の中空糸を内蔵するにも関わらず、真円
度偏りを3%以下にすることにより、さらに好ましくは
真円度偏りを1%以下にすることによって、低分子物質
の除去性能のバラツキが驚くほど小さくなることを見出
した。ここでいう真円度偏りの下限は、定義から自ずと
0%である。
The circularity deviation in this test is a parameter showing the deviation of the hollow fiber bundle diameter on the blood contact surface.
The small deviation indicates that the difference between the maximum diameter and the minimum diameter of the bundle is small, and that the hollow fibers are evenly present in a perfect circle on the blood contact surface. Therefore, the inventors focused on the roundness deviation, and made a detailed study on the manufacturing conditions of the dialyzer, and conducted a thorough study of the relationship between the roundness deviation and the substance removal performance of the dialyzer, and found that the same number of hollow fibers were used. Despite being built-in, the deviation in roundness deviation is surprisingly reduced by setting the deviation in circularity to 3% or less, and more preferably, setting the deviation in circularity to 1% or less. Found. The lower limit of the circularity deviation referred to here is 0% by definition.

【0016】この条件を満たす透析器が課題に掲げた目
的を達成する理由は必ずしも明確ではないが、中空糸束
の真円度偏りを抑制することによって、中空糸束と容器
間、特に透析液が流入するあるいは流出する部分近傍に
おいて、中空糸束と容器間の空隙が一定となり、透析液
の流れが個々の透析器でバラツキが少なくなって目的を
達する透析器となったと推測される。
Although the reason why the dialyzer satisfying these conditions achieves the object stated in the subject is not always clear, it is possible to suppress the roundness deviation of the hollow fiber bundle to prevent the hollow fiber bundle from being rounded, especially between the hollow fiber bundle and the container. It is presumed that the space between the hollow fiber bundle and the container became constant in the vicinity of the inflow or outflow area of the dialysate, and the flow of the dialysate was reduced among the individual dialysers, resulting in a dialyzer that achieved its purpose.

【0017】さらに、血液透析器の血液接触面における
透析器容器に対する中空糸束の占有率を87%以上と
し、かつ中空糸束の真円度偏りを3%以下とすることに
より、透析治療終了後、透析器の血液導入部に血液が残
留することが無く、かつ低分子物質の除去性能のバラツ
キが少ない透析器とすることができた。
Further, the dialysis treatment is completed by setting the occupation ratio of the hollow fiber bundle to the dialyzer container on the blood contact surface of the hemodialyzer to be 87% or more and the circularity deviation of the hollow fiber bundle to be 3% or less. After that, it was possible to obtain a dialyzer in which blood did not remain in the blood introducing part of the dialyzer and variation in removal performance of low molecular weight substances was small.

【0018】従来、血液透析器は一般に、数百から数万
本の中空糸をフィルムに巻き、ロート状のガイドを介し
て透析器容器に挿入し、さらにポッティング材を受ける
冶具を取り付けた上で、ポッティング材を遠心しながら
注ぎこむか、あるいは静置した樹脂に漬け込み、中空糸
を容器に固定している。後者の静置した樹脂に中空糸束
を漬け込む方法では、中空糸間に樹脂が浸入しづらく、
数万本にもなる中空糸すべてを容器に固定することが難
しいため、現在では一般に、遠心しながらポッティング
材を注ぎ込む方法が用いられている。しかしながら、こ
の方法ではポッティング材が遠心力により勢い良く流れ
込むため、中空糸が倒れる傾向にあり、中空糸1本1本
を直立させること、および血液接触面において中空糸束
を真円に保つことが難しかった。これらの現象は、公知
の技術である中空糸束先端をあらかじめ樹脂等で固定し
た上でポッティング材を遠心注入し、束の乱れを回避す
る方法(特開 2000-210538、特開2000-210539)では、仮
に中空糸を固定しているので、中空糸を整列させること
は可能であっても、ポッティング材を注入したとき、中
空糸束の広がり、即ち本明細書中の血液接触面における
中空糸束の占有率は抑制される傾向にあった。
Conventionally, in a hemodialyzer, generally, hundreds to tens of thousands of hollow fibers are wound on a film, inserted into a dialyzer container through a funnel-shaped guide, and a jig for receiving a potting material is attached. The potting material is centrifugally poured into the potting material, or it is dipped in a resin that has been left still to fix the hollow fiber to the container. In the latter method of immersing the hollow fiber bundle in the standing resin, it is difficult for the resin to penetrate between the hollow fibers,
Since it is difficult to fix all tens of thousands of hollow fibers to a container, a method of pouring a potting material while centrifuging is generally used at present. However, in this method, the potting material flows in vigorously due to the centrifugal force, so that the hollow fibers tend to fall down, and it is possible to make each hollow fiber stand upright and to keep the bundle of hollow fibers in a perfect circle on the blood contact surface. was difficult. These phenomena are known techniques in which the tip of the hollow fiber bundle is fixed in advance with resin or the like and then the potting material is centrifugally injected to avoid disorder of the bundle (JP 2000-210538, JP 2000-210539). Since the hollow fibers are temporarily fixed, the hollow fibers can be aligned, but when the potting material is injected, the hollow fiber bundle spreads, that is, the hollow fibers on the blood contact surface in the present specification. The occupancy of the bundle tended to be suppressed.

【0019】そこで発明者らは透析器容器に挿入する直
前の中空糸束の状態に注目し、鋭意検討を進めた結果、
以下の発明に至った。即ち、フィルムに包装された中空
糸束を、複数のローラー間に置き、一定時間回転させる
ことによって、フィルム内で中空糸を真円状とし、その
後に透析器容器に挿入する方法を見出した。複数のロー
ラーとは、具体的には、多孔質ウレタンなどのスポンジ
を表面に貼り付けた2本のローラーか、より好ましくは
3本のローラーを使用し、各ローラーに中空糸束フィル
ムが常に接する状態で、一定時間、束を回転する。ロー
ラーの接圧、回転数、回転時間により、フィルム内の中
空糸の真円状態は比較的簡単に制御できるが、たとえば
長時間処理しすぎると、フィルム内で中空糸が広がりす
ぎて、その後実施する血液透析器容器への挿入が困難に
なるため、使用する容器、中空糸束に合わせてローラー
接圧、回転数、回転時間を定める必要がある。特に、ロ
ーラーの回転数とローラー周長の積であるローラー周速
度は、複数本あるローラーのそれぞれの周速度が同一で
あると、中空糸はフィルム内で均一に分散されず、周速
度を異なる様にすると、束の外周から中央部まで分散さ
れることを見出した。
Therefore, the inventors have paid attention to the state of the hollow fiber bundle immediately before inserting it into the dialyzer container, and as a result of earnest study,
The following inventions have been reached. That is, the inventors have found a method in which a hollow fiber bundle wrapped in a film is placed between a plurality of rollers and rotated for a certain period of time to make the hollow fibers into a perfect circle in the film, and then inserting the hollow fiber into a dialyzer container. Specifically, the plurality of rollers are two rollers having a sponge such as porous urethane attached on the surface thereof, or more preferably three rollers, and the hollow fiber bundle film is always in contact with each roller. Then, rotate the bundle for a certain period of time. The perfect circle state of the hollow fibers in the film can be controlled relatively easily by the contact pressure of the roller, the number of rotations, and the rotation time.However, if the treatment is carried out for too long, the hollow fibers will spread too much in the film and Since it becomes difficult to insert it into the hemodialyzer container, it is necessary to determine the roller contact pressure, rotation speed, and rotation time according to the container and hollow fiber bundle used. In particular, the roller peripheral speed, which is the product of the number of rotations of the roller and the roller peripheral length, is different when the peripheral speeds of a plurality of rollers are the same, and the hollow fibers are not uniformly dispersed in the film. By doing so, it was found that the bundle was dispersed from the outer periphery to the central portion.

【0020】この処理で中空糸がフィルム内で分散する
理由は、中空糸同士が擦れて静電気を起こすため反発し
合って、フィルム内で膨らみ分散して真円状となるか、
もしくは、この処理を長時間行うと外観上、整列状態の
中空糸が段々と乱れていくことから、処理を行うことで
中空糸一本一本がフィルム内で移動して、中空糸がお互
いに重なりあうようになるため、フィルム内で膨らんで
分散して真円状となるものと考えられる。
The reason why the hollow fibers are dispersed in the film by this treatment is that the hollow fibers are rubbed with each other to generate static electricity and repel each other to swell and disperse in the film to form a perfect circle.
Or, if this treatment is carried out for a long time, the hollow fibers in an aligned state gradually become disordered in appearance, so that by performing the treatment, the hollow fibers move in the film one by one, and the hollow fibers move to each other. Since they overlap with each other, it is considered that they swell and disperse in the film to form a perfect circle.

【0021】ここで用いられる血液透析用膜の材質は特
に限定されないが、血液透析用途に用いられる公知の材
質であれば、たとえば再生セルロース系膜や、ポリスル
ホンを基材とし、親水性を得るために PVP、ポリビニル
アルコール、ポリエチレングリコールなどの親水性高分
子を有したポリスルホン系膜、あるいはセルローストリ
アセテート膜、ポリメチルメタクリレート膜などを用い
ることができる。なかでも、ポリスルホンにPVPを添
加してなる中空糸膜は本発明の好ましい具体例として挙
げられるが、これはポリスルホンが疎水性の性質を持つ
ため、本処理を施したときに多くの静電気が発生し、中
空糸同士が静電的に反発しあって嵩だかになるものと考
えられる。また、ポリスルホン膜は適度な糸の腰(適度
なしなやかさ)を有するために、本処理を施したとき
に、もつれることなく中空糸が移動しやすく、中空糸が
お互いに重なり合う現象が起こって嵩だかになりやすい
ものと考えられる。
The material of the hemodialysis membrane used here is not particularly limited, but if it is a known material used for hemodialysis, for example, a regenerated cellulose-based membrane or polysulfone is used as a base material to obtain hydrophilicity. In addition, a polysulfone-based film having a hydrophilic polymer such as PVP, polyvinyl alcohol, or polyethylene glycol, a cellulose triacetate film, or a polymethylmethacrylate film can be used. Among them, a hollow fiber membrane obtained by adding PVP to polysulfone is mentioned as a preferred specific example of the present invention. However, since polysulfone has a hydrophobic property, a lot of static electricity is generated when this treatment is performed. However, it is considered that the hollow fibers repel each other electrostatically and become bulky. In addition, since the polysulfone membrane has a moderate elasticity (moderate pliability), when this treatment is performed, the hollow fibers easily move without being entangled, and the hollow fibers may overlap with each other. It is thought that it is easy to get rid of it.

【0022】また、中空糸の形状として、従来技術で述
べた中空糸間にスペーサーフィラメントを入れた束や、
クリンプを与えた中空糸にも応用可能であるが、特に好
ましい実施様態として、中空糸が直線状である中空糸、
いわゆるストレート糸が挙げられる。これは、ローラー
間で束を回転処理したときに、中空糸の移動がより容易
で、中空糸がお互いに重なりあって、フィルム内で膨ら
む現象が起こりやすいためと考えられる。本発明に用い
ることができるポリスルホン系高分子に PVPを添加して
なる中空糸型血液処理用膜は、たとえば特開平12-13542
2 に記載の公知の方法によって製造された中空糸を、筒
状のフィルムに挿入し中空糸束とする。
Further, as the shape of the hollow fiber, a bundle in which spacer filaments are inserted between the hollow fibers described in the prior art,
Although it is applicable to a crimped hollow fiber, as a particularly preferred embodiment, the hollow fiber is a straight hollow fiber,
So-called straight yarn can be mentioned. It is considered that this is because when the bundle is rotated between the rollers, the hollow fibers are more easily moved, and the hollow fibers are overlapped with each other, so that the phenomenon of swelling in the film easily occurs. A hollow fiber type blood treatment membrane obtained by adding PVP to a polysulfone-based polymer that can be used in the present invention is disclosed in, for example, JP-A-12-13542.
The hollow fiber produced by the known method described in 2 is inserted into a tubular film to form a hollow fiber bundle.

【0023】得られた中空糸束を周速度の異なる複数の
ローラー間に置き、一定時間回転させた後、筒状の容器
に装填、中空糸を覆っていたフィルムを抜き去った後、
遠心機にセットしてポリウレタン樹脂等のポッティング
材を注入して容器に接着固定する。余分な接着剤を切断
除去して得られた半製品に栓、包装材を施した後、滅菌
操作を行い、本発明の血液透析器とすることができる。
上記の半製品に、純水や、ピロ亜硫酸ナトリウム、アセ
トンソジウムバイサルファイト等の水溶性の物質を溶存
させた液を充填し、施栓後、滅菌を行っても差し支えな
い。また、滅菌操作は、エチレンオキサイドガス滅菌ま
たは高圧蒸気滅菌またはγ線などの放射線を照射する放
射線滅菌のいずれかの方法を、任意に選択し使用するこ
とができる。このようにして得られた血液透析器は、血
液透析器の中空糸包埋部の血液残留が少ない血液透析器
となり、かつ、または、透析器物質除去性能のばらつき
が少なくなることを見出した。
The obtained hollow fiber bundle was placed between a plurality of rollers having different peripheral speeds, rotated for a certain period of time, loaded into a cylindrical container, and the film covering the hollow fibers was removed,
Set in a centrifuge, inject potting material such as polyurethane resin, and adhere and fix to a container. The semi-finished product obtained by cutting and removing the excess adhesive is provided with a stopper and a packaging material, and then sterilized to obtain the hemodialyzer of the present invention.
The above semi-finished product may be filled with pure water or a liquid in which a water-soluble substance such as sodium pyrosulfite and acetone sodium bisulfite is dissolved, and after plugging, sterilization may be performed. As the sterilization operation, any method of ethylene oxide gas sterilization, high-pressure steam sterilization, or radiation sterilization of irradiating radiation such as γ-rays can be arbitrarily selected and used. It has been found that the hemodialyzer thus obtained is a hemodialyzer with less residual blood in the hollow fiber embedded portion of the hemodialyzer and / or has less variation in dialyzer substance removal performance.

【0024】[0024]

【実施例】以下に本発明をさらに具体的に説明するため
に実施例および比較例を挙げて説明するが本発明はこれ
らの実施例により限定されるものではない。なお、実施
例、比較例中の血液接触面における容器内径に対する中
空糸束の占有率測定、真円度偏り測定、血液導入部残血
試験は以下の方法に従った。
EXAMPLES The present invention will be described below in more detail with reference to Examples and Comparative Examples, but the present invention is not limited to these Examples. In the Examples and Comparative Examples, the occupancy rate measurement of the hollow fiber bundle with respect to the inner diameter of the container on the blood contact surface, the circularity deviation measurement, and the blood introduction part residual blood test were performed according to the following methods.

【0025】(中空糸束占有率測定)中空糸包埋部の血
液接触面における容器内径に対する中空糸束の占有率
は、血液透析器の血液接触面における容器内径に対する
中空糸束径の割合を示す。容器内径は血液透析器の血液
接触面における容器内径を少なくとも5箇所以上、ノギ
ス等を用いて測定し、その最大値および最小値の算術平
均値を容器内径とする。一方、中空糸束径は、中空糸包
埋部の血液接触面を正視し、極端に亀裂を生じたように
束が割れている部分を除き、中空糸束の径を最低5箇所
以上測定して最大径および最小径を求め、その算術平均
値を中空糸束径として、下式
(Measurement of Hollow Fiber Bundle Occupancy Rate) The occupancy rate of the hollow fiber bundle to the inner diameter of the container on the blood contact surface of the hollow fiber embedded portion is defined as the ratio of the hollow fiber bundle diameter to the inner diameter of the container on the blood contact surface of the hemodialyzer. Show. For the inner diameter of the container, the inner diameter of the container on the blood contact surface of the hemodialyzer is measured at least at five points using calipers, and the arithmetic mean value of the maximum and minimum values is taken as the inner diameter of the container. On the other hand, the diameter of the hollow fiber bundle is measured by directly looking at the blood contact surface of the hollow fiber embedding portion and measuring the diameter of the hollow fiber bundle at a minimum of 5 points or more, excluding the portion where the bundle is cracked as if an extreme crack had occurred. The maximum and minimum diameters are calculated by using the

【数1】により占有率を算出した。The occupancy rate was calculated by the following equation.

【0026】[0026]

【数1】 占有率(%)=100 ×中空糸束径÷容器内径 (1) [Equation 1]       Occupancy (%) = 100 x hollow fiber bundle diameter ÷ container inner diameter (1)

【0027】(真円度偏り測定)中空糸包埋部を正視
し、極端に亀裂を生じたように束が割れている部分を除
き、中空糸束の径を最低5箇所以上、ノギス等により実
測して、中空糸束の最大径および最小径とし、下式
(2)により真円度を算出した。
(Measurement of roundness deviation) By emphasizing the hollow fiber embedding portion, the diameter of the hollow fiber bundle should be at least 5 points or more by a caliper or the like, except for the portion where the bundle is broken like an extremely cracked portion. The roundness was calculated by the following equation (2) by actually measuring and setting the maximum diameter and the minimum diameter of the hollow fiber bundle.

【0028】[0028]

【数2】 真円度偏り(%)=100 ×(最大径−最小径)÷最小径 (2) [Equation 2]       Roundness deviation (%) = 100 x (maximum diameter-minimum diameter) ÷ minimum diameter (2)

【0029】(血液導入部残血試験)血液導入部残血試
験は、牛全血(37℃、総タンパク含量6.5g/dl)を流速20
0ml/分で血液側に15分間流し、その後、生理食塩水を流
速 50ml/分で4分間流した。その後、血液導入部を観察
し、外周に血液が残っているかを目視により判定した。
(Blood introduction part residual blood test) In the blood introduction part residual blood test, bovine whole blood (37 ° C, total protein content 6.5 g / dl) was used at a flow rate of 20.
The blood was flown at 0 ml / min for 15 minutes, and then physiological saline was flown at a flow rate of 50 ml / min for 4 minutes. Then, the blood introducing part was observed, and it was visually determined whether blood remained on the outer periphery.

【0030】(低分子物質除去性能測定)低分子物質
(尿素)除去性能測定については、ダイアライザー性能
評価基準(日本人工臓器学会、昭和57年9月)に従っ
て、血液側溶液流速200ml/分、透析液側液流速5
00ml/分で実施し、血液入り口側の尿素濃度(Ci
n)、出口側の尿素濃度(Cout)から、下式
(Low molecular weight substance removal performance measurement) Regarding the low molecular weight substance (urea) removal performance measurement, according to the dialyzer performance evaluation standard (Japan Society for Artificial Organs, September 1982), blood side solution flow rate 200 ml / min, dialysis Liquid side liquid flow rate 5
It was carried out at 00 ml / min, and the urea concentration (Ci
n) and the urea concentration (Cout) on the outlet side,

【数3】により溶質のクリアランスを算出した。The solute clearance was calculated by the following equation.

【数3】クリアランス=Cin/Cout×200 ここで得られる数値の単位はml/分となり、血液側溶
液中(本測定においては200ml/分)のどれぐらい
の溶液から溶質が除去されたかを示す。
[Equation 3] Clearance = Cin / Cout × 200 The unit of the numerical value obtained here is ml / min, which indicates how much solution in the blood side solution (200 ml / min in this measurement) the solute was removed. .

【0031】[0031]

【実施例1】図1に示すように、内径 200μm 、膜厚45
μm のポリスルホン中空糸 9200 本を筒状フィルムに入
れた中空糸束(4) を準備し、外表面にスポンジ層を有す
る外径45mmのローラー3本(1,2,3) を、全てのローラー
が中空糸束に接し、かつ、ローラーの円の中心が正三角
形の頂点になるように配置し、3本のローラーの回転速
度を200rpm、250rpm、280rpmにして、2秒間中空糸束を
回転させた。中空糸束は筒状フィルム内で膨らんだ状態
となり、この中空糸束をポリカーボネート製筒状容器に
挿入した後、遠心機にセットしてウレタン樹脂を、注
入、ウレタン樹脂のゲルアップ後、遠心機より取り出し
た。ウレタン樹脂を十分固化させる為、45℃の養生庫に
24時間入れた後、余分なウレタン樹脂を切断し、血液導
入部部品を取り付け、純水を充填し、栓を施して、ガン
マ線 25kGyを照射し、試験品(本発明品)を得た。
Example 1 As shown in FIG. 1, an inner diameter of 200 μm and a film thickness of 45
Prepare a hollow fiber bundle (4) containing 9200 μm polysulfone hollow fibers in a tubular film, and use three rollers (1, 2, 3) with an outer diameter of 45 mm and a sponge layer on the outer surface for all rollers. Are in contact with the hollow fiber bundle, and the centers of the circles of the rollers are at the vertices of an equilateral triangle, and the rotation speed of the three rollers is 200 rpm, 250 rpm, 280 rpm, and the hollow fiber bundle is rotated for 2 seconds. It was The hollow fiber bundle is in a state of swelling in the tubular film, after inserting this hollow fiber bundle into the polycarbonate cylindrical container, set it in the centrifuge and inject the urethane resin, gel up the urethane resin, centrifuge I took it out. In order to cure urethane resin sufficiently
After being put for 24 hours, excess urethane resin was cut, a blood introducing part component was attached, pure water was filled, a stopper was applied, and gamma rays of 25 kGy were irradiated to obtain a test product (product of the present invention).

【0032】得られた試験品について、5本をランダム
に取り出し、尿素のクリアランス測定を行って平均値と
標準偏差を算出した。更に、同じ試験品に対し、牛血液
を用いた残血試験を行った後、血液導入部を解体して、
中空糸包埋部の血液接触面における容器内径に対する中
空糸束の占有率、および中空糸束の真円度偏りを測定・
算出した。得られた数値を表1に示した。
Five pieces of the obtained test product were taken out at random, urea clearance was measured, and the average value and standard deviation were calculated. Furthermore, after performing a residual blood test using bovine blood on the same test product, disassemble the blood introducing part,
Measures the occupancy of the hollow fiber bundle with respect to the inner diameter of the container on the blood contact surface of the hollow fiber embedding part and the circularity deviation of the hollow fiber bundle.
It was calculated. The obtained numerical values are shown in Table 1.

【0033】[0033]

【表1】 [Table 1]

【0034】[0034]

【実施例2】内径 200μm 、膜厚45μm のポリスルホン
中空糸9200本を筒状フィルムに入れた中空糸束を準備
し、外表面にスポンジ層を有する外径45mmのローラー3
本を、全てのローラーが中空糸束に接し、かつ、ローラ
ーの円の中心が正三角形の頂点になるように配置し、3
本のローラーの回転速度を200rpm、250rpm、280rpmにし
て、4秒間中空糸束を回転させた。得られた中空糸束を
実施例1と同じ処理を施し、得られた試験品(本発明
品)について、実施例1と同じ試験を行って得た数値を
表1に示した。
[Example 2] A hollow fiber bundle was prepared in which 9200 polysulfone hollow fibers having an inner diameter of 200 µm and a film thickness of 45 µm were put in a tubular film, and a roller 3 having an outer diameter of 45 mm and having a sponge layer on the outer surface.
Arrange the book so that all the rollers are in contact with the hollow fiber bundle and the center of the circle of the rollers is the apex of an equilateral triangle.
The rotation speed of the rollers of the book was set to 200 rpm, 250 rpm, and 280 rpm, and the hollow fiber bundle was rotated for 4 seconds. The obtained hollow fiber bundle was subjected to the same treatment as in Example 1, and the obtained test product (product of the present invention) was subjected to the same test as in Example 1 and the numerical values obtained are shown in Table 1.

【0035】[0035]

【実施例3】内径 200μm 、膜厚45μm のポリスルホン
中空糸9200本を筒状フィルムに入れた中空糸束を準備
し、外表面にスポンジ層を有する外径45mmのローラー3
本を、全てのローラーが中空糸束に接し、かつ、ローラ
ーの円の中心が正三角形の頂点になるように配置し、3
本のローラーの回転速度を300rpm、350rpm、380rpmにし
て、2秒間中空糸束を回転させた。得られた中空糸束を
実施例1と同じ処理を施し、得られた試験品(本発明
品)について、実施例1と同じ試験を行って得た数値を
表1に示した。
Example 3 A hollow fiber bundle having 9200 polysulfone hollow fibers having an inner diameter of 200 μm and a film thickness of 45 μm put in a tubular film was prepared, and a roller 3 having an outer diameter of 45 mm and having a sponge layer on the outer surface was prepared.
Arrange the book so that all the rollers are in contact with the hollow fiber bundle and the center of the circle of the rollers is the apex of an equilateral triangle.
The rotation speed of the rollers of the book was set to 300 rpm, 350 rpm, and 380 rpm, and the hollow fiber bundle was rotated for 2 seconds. The obtained hollow fiber bundle was subjected to the same treatment as in Example 1, and the obtained test product (product of the present invention) was subjected to the same test as in Example 1 and the numerical values obtained are shown in Table 1.

【0036】[0036]

【実施例4】内径 200μm 、膜厚45μm のポリスルホン
中空糸9200本を筒状フィルムに入れた中空糸束を準備
し、外表面にスポンジ層を有する外径45mmのローラー3
本を、全てのローラーが中空糸束に接し、かつ、ローラ
ーの円の中心が正三角形の頂点になるように配置し、3
本のローラーの回転速度を300rpm、350rpm、380rpmにし
て、4秒間中空糸束を回転させた。得られた中空糸束を
実施例1と同じ処理を施し、得られた試験品(本発明
品)について、実施例1と同じ試験を行って得た数値を
表1に示した。
[Example 4] A hollow fiber bundle was prepared in which 9200 polysulfone hollow fibers having an inner diameter of 200 µm and a film thickness of 45 µm were put in a tubular film, and a roller 3 having an outer diameter of 45 mm and having a sponge layer on the outer surface was prepared.
Arrange the book so that all the rollers are in contact with the hollow fiber bundle and the center of the circle of the rollers is the apex of an equilateral triangle.
The rotation speed of the rollers of the book was set to 300 rpm, 350 rpm, and 380 rpm, and the hollow fiber bundle was rotated for 4 seconds. The obtained hollow fiber bundle was subjected to the same treatment as in Example 1, and the obtained test product (product of the present invention) was subjected to the same test as in Example 1 and the numerical values obtained are shown in Table 1.

【0037】[0037]

【比較例1】内径 200μm 、膜厚45μm のポリスルホン
中空糸9200本を筒状フィルムに入れた中空糸束を準備
し、ローラー間で回転させることなく、ポリカーボネー
ト製円筒容器に挿入し、ウレタン樹脂による固定以降、
実施例1と同じ処理を施し、得られた試験品(対照)に
ついて、実施例1と同じ試験を行って得た数値を表1に
示した。
[Comparative Example 1] A hollow fiber bundle was prepared in which 9200 polysulfone hollow fibers having an inner diameter of 200 μm and a film thickness of 45 μm were put in a tubular film, and the hollow fiber bundle was inserted into a polycarbonate cylindrical container without being rotated between rollers and was made of urethane resin. After fixing,
Table 1 shows the numerical values obtained by performing the same test as in Example 1 on the test product (control) obtained by the same treatment as in Example 1.

【0038】[0038]

【発明の効果】本発明により、非常に簡便な方法によっ
て、血液透析治療後、血液透析器の中空糸埋包部の血液
接触面における血液残留を少なくすることができ、透析
器の物質除去性能のバラツキを減少させることができ
た。
EFFECTS OF THE INVENTION According to the present invention, by a very simple method, it is possible to reduce the blood residue on the blood contact surface of the hollow fiber embedding part of the hemodialyzer after the hemodialysis treatment, and to remove the substance of the dialyzer. It was possible to reduce the variation of the.

【図面の簡単な説明】[Brief description of drawings]

【図1】実施例1の中空糸束を複数のローラー間に置き
ローラーを回転させたときのローラーと中空糸束との位
置関係を示す平面図。
FIG. 1 is a plan view showing a positional relationship between a roller and a hollow fiber bundle when the hollow fiber bundle of Example 1 is placed between a plurality of rollers and the rollers are rotated.

【符号の説明】[Explanation of symbols]

1, 2, 3・・ローラー 4 ・・・・中空糸束 1, 2, 3 ... Roller 4 ··· Hollow fiber bundle

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) B01D 63/02 B01D 63/02 71/68 71/68 Fターム(参考) 4C077 AA12 BB01 CC01 EE01 EE03 LL05 PP15 4D006 GA13 HA02 HA18 JA02A JA13A JB04 MA01 MA34 MB01 MC62 MC62X PA01 PB09 PC47 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) B01D 63/02 B01D 63/02 71/68 71/68 F term (reference) 4C077 AA12 BB01 CC01 EE01 EE03 LL05 PP15 4D006 GA13 HA02 HA18 JA02A JA13A JB04 MA01 MA34 MB01 MC62 MC62X PA01 PB09 PC47

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 中空糸束が筒状プラスチック容器内に挿
入され、束の両端部がポッティング材で包埋された血液
透析器において、中空糸包埋部の血液接触面における容
器内径に対する中空糸束の占有率が87%以上である血液
透析器。
1. A hemodialyzer in which a bundle of hollow fibers is inserted into a cylindrical plastic container, and both ends of the bundle are embedded with potting material. A hemodialyzer with an occupancy rate of 87% or more.
【請求項2】 中空糸包埋部の血液接触面における中空
糸束の真円度偏りが3%以下である請求項1記載の血液
透析器。
2. The hemodialyzer according to claim 1, wherein the roundness deviation of the roundness of the hollow fiber bundle at the blood contact surface of the hollow fiber embedded portion is 3% or less.
【請求項3】 中空糸の形状が繊維軸方向に沿って直線
状である請求項1又は2記載の血液透析器。
3. The hemodialyzer according to claim 1, wherein the hollow fiber has a linear shape along the fiber axis direction.
【請求項4】 中空糸の素材がポリスルホンを基材とす
る請求項1乃至3のいずれかに記載の血液透析器。
4. The hemodialyzer according to claim 1, wherein the material of the hollow fiber is polysulfone as a base material.
【請求項5】 中空糸束を筒状プラスチック容器内に挿
入し、束の両端部をポッティング材で包埋する血液透析
器の製造方法において、予めフィルム巻きされた中空糸
束を周速度の異なる複数のローラー間に置き、一定時間
回転させた後、筒状プラスチック容器に挿入しポッティ
ング材で固定することを特徴とする請求項1乃至4のい
ずれかに記載の血液透析器の製造方法。
5. A method for manufacturing a hemodialyzer in which a hollow fiber bundle is inserted into a cylindrical plastic container and both ends of the bundle are embedded with potting material, wherein hollow film bundles preliminarily film-wound have different peripheral speeds. The method for producing a hemodialyzer according to any one of claims 1 to 4, wherein the hemodialyzer is placed between a plurality of rollers, rotated for a certain period of time, and then inserted into a cylindrical plastic container and fixed with a potting material.
JP2001363791A 2001-11-29 2001-11-29 Hemodialyzer and method for manufacturing the same Expired - Lifetime JP4069998B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001363791A JP4069998B2 (en) 2001-11-29 2001-11-29 Hemodialyzer and method for manufacturing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001363791A JP4069998B2 (en) 2001-11-29 2001-11-29 Hemodialyzer and method for manufacturing the same

Publications (2)

Publication Number Publication Date
JP2003159325A true JP2003159325A (en) 2003-06-03
JP4069998B2 JP4069998B2 (en) 2008-04-02

Family

ID=19174078

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001363791A Expired - Lifetime JP4069998B2 (en) 2001-11-29 2001-11-29 Hemodialyzer and method for manufacturing the same

Country Status (1)

Country Link
JP (1) JP4069998B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005328982A (en) * 2004-05-19 2005-12-02 Toyobo Co Ltd Highly water-permeable hollow fiber membrane type hemocatharsis apparatus
JP2006297223A (en) * 2005-04-18 2006-11-02 Nikkiso Co Ltd Dispersion method of hollow fiber bundle and hollow fiber bundle dispersion device
JP2006297222A (en) * 2005-04-18 2006-11-02 Nikkiso Co Ltd Dispersion method of hollow fiber bundle and hollow fiber bundle dispersion device
JP2007313394A (en) * 2006-05-24 2007-12-06 Daicen Membrane Systems Ltd Membrane module and its assembly method
WO2010118854A1 (en) 2009-04-14 2010-10-21 Fresenius Medical Care Deutschland Gmbh Filter device comprising heterogeneously distributed hollow fibers and method for the production thereof
EP3238758A4 (en) * 2014-12-25 2017-11-08 Asahi Kasei Medical Co., Ltd. Hemodiafilter and hemodiafiltration device

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102020203553A1 (en) 2020-03-19 2021-09-23 B.Braun Avitum Ag Dialyzer, dialysis machine and kit and method for producing a dialyzer

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005328982A (en) * 2004-05-19 2005-12-02 Toyobo Co Ltd Highly water-permeable hollow fiber membrane type hemocatharsis apparatus
JP4501530B2 (en) * 2004-05-19 2010-07-14 東洋紡績株式会社 Highly permeable hollow fiber membrane blood purifier
JP2006297223A (en) * 2005-04-18 2006-11-02 Nikkiso Co Ltd Dispersion method of hollow fiber bundle and hollow fiber bundle dispersion device
JP2006297222A (en) * 2005-04-18 2006-11-02 Nikkiso Co Ltd Dispersion method of hollow fiber bundle and hollow fiber bundle dispersion device
JP4549220B2 (en) * 2005-04-18 2010-09-22 日機装株式会社 Hollow fiber bundle dispersion method and hollow fiber bundle dispersion device
JP4549221B2 (en) * 2005-04-18 2010-09-22 日機装株式会社 Hollow fiber bundle dispersion method and hollow fiber bundle dispersion device
JP2007313394A (en) * 2006-05-24 2007-12-06 Daicen Membrane Systems Ltd Membrane module and its assembly method
WO2010118854A1 (en) 2009-04-14 2010-10-21 Fresenius Medical Care Deutschland Gmbh Filter device comprising heterogeneously distributed hollow fibers and method for the production thereof
DE102009017413A1 (en) 2009-04-14 2010-11-18 Fresenius Medical Care Deutschland Gmbh Filter device and method for producing a filter device
JP2012523319A (en) * 2009-04-14 2012-10-04 フレゼニウス メディカル ケアー ドイチュラント ゲゼルシャフト ミット ベシュレンクテル ハフツング Filter device and method of manufacturing filter device
EP3238758A4 (en) * 2014-12-25 2017-11-08 Asahi Kasei Medical Co., Ltd. Hemodiafilter and hemodiafiltration device

Also Published As

Publication number Publication date
JP4069998B2 (en) 2008-04-02

Similar Documents

Publication Publication Date Title
EP2957306B1 (en) Blood purification column
JP6565187B2 (en) Porous membrane, blood purification module incorporating porous membrane, and method for producing porous membrane
JPWO2008093654A1 (en) Hollow fiber membrane and hollow fiber membrane module incorporating the same
JP6895754B2 (en) Hemodiafiltration filter and hemodiafiltration device
JP4069998B2 (en) Hemodialyzer and method for manufacturing the same
JP2008155009A (en) Hollow fiber membrane type blood purification module and its manufacturing method
JP4873665B2 (en) Hollow fiber membrane for blood purification
JP5601752B2 (en) Hollow fiber membrane and hollow fiber membrane type blood purification module
JP4923902B2 (en) Hollow fiber membrane for blood purification and method for producing the same
JP3684676B2 (en) Method for producing polysulfone-based hollow fiber artificial kidney and artificial kidney
JPH11104235A (en) Polysulfone hollow fiber type artificial kidney and its production
JP3821557B2 (en) Blood purifier manufacturing method
JP7224104B2 (en) Dialysis device with improved internal filtration and method of manufacture
JP2017185221A (en) Adsorption column
US20220379000A1 (en) Fiber bundle, method for producing same, and purification column
JP2009078121A (en) Blood purifier and its production method
JP2006075609A (en) Blood purification apparatus
JP2006000373A (en) Highly-permeable hollow fiber membrane type blood purifier
JP2005237755A (en) Hemodialyzer
JP2681705B2 (en) Method for manufacturing body fluid treatment device
JP2000350926A (en) Polysulfone hollow fiber membrane of selective permeablility
JP2009095825A (en) Hollow fiber membrane or hollow fiber membrane module, and its manufacturing method
JP2710710B2 (en) Fluid separator
JP5408197B2 (en) Method for producing hollow fiber membrane for blood purification
JP2007260345A (en) Permselective separation membrane module

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040622

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070815

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071012

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080109

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080109

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4069998

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110125

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120125

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120125

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130125

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130125

Year of fee payment: 5

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130125

Year of fee payment: 5

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140125

Year of fee payment: 6

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term